Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$1M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 6 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 21 most recent Form 4 transactions.
| Jul 29 | MAZE | Maze Therapeutics, Inc. | SSELL◷ | 7,100 | $27.31 | $193.9K | -21.0% | Open the original filing on SEC.gov |
| Jul 29 | MAZE | Maze Therapeutics, Inc. | MEXER◷ | 7,500 | $10.42 | $78.2K | +28.6% | Open the original filing on SEC.gov |
| Jun 29 | MAZE | Maze Therapeutics, Inc. | MEXER◷◆ | 7,500 | — | — | — | Open the original filing on SEC.gov |
| Jun 29 | MAZE | Maze Therapeutics, Inc. | SSELL◷ | 7,500 | $28.02 | $210.2K | -22.2% | Open the original filing on SEC.gov |
| Jun 29 | MAZE | Maze Therapeutics, Inc. | MEXER◷ | 7,500 | $10.42 | $78.2K | +28.6% | Open the original filing on SEC.gov |
| May 29 | MAZE | Maze Therapeutics, Inc. | MEXER◷◆ | 7,500 | — | — | — | Open the original filing on SEC.gov |
| May 29 | MAZE | Maze Therapeutics, Inc. | SSELL◷ | 7,500 | $26.34 | $197.6K | -23.2% | Open the original filing on SEC.gov |
| May 29 | MAZE | Maze Therapeutics, Inc. | MEXER◷ | 7,500 | $10.42 | $78.2K | +30.2% | Open the original filing on SEC.gov |
| May 4 | MAZE | Maze Therapeutics, Inc. | MEXER◆ | 5,985 | — | — | — | Open the original filing on SEC.gov |
| May 4 | MAZE | Maze Therapeutics, Inc. | MEXER◆ | 8,320 | — | — | — | Open the original filing on SEC.gov |
| May 4 | MAZE | Maze Therapeutics, Inc. | MEXER | 5,985 | $10.42 | $62.4K | +31.8% | Open the original filing on SEC.gov |
| May 4 | MAZE | Maze Therapeutics, Inc. | MEXER | 8,320 | $10.42 | $86.7K | +79.2% | Open the original filing on SEC.gov |
| Apr 29 | MAZE | Maze Therapeutics, Inc. | MEXER◷◆ | 7,500 | — | — | — | Open the original filing on SEC.gov |
| Apr 29 | MAZE | Maze Therapeutics, Inc. | SSELL◷ | 7,500 | $25.37 | $190.3K | -41.7% | Open the original filing on SEC.gov |
| Apr 29 | MAZE | Maze Therapeutics, Inc. | MEXER◷ | 7,500 | $10.42 | $78.2K | +71.4% | Open the original filing on SEC.gov |
| Mar 30 | MAZE | Maze Therapeutics, Inc. | MEXER◷◆ | 7,500 | — | — | — | Open the original filing on SEC.gov |
| Mar 30 | MAZE | Maze Therapeutics, Inc. | SSELL◷ | 790 | $30.02 | $23.7K | -7.0% | Open the original filing on SEC.gov |
| Mar 30 | MAZE | Maze Therapeutics, Inc. | SSELL◷ | 6,710 | $29.26 | $196.3K | -37.3% | Open the original filing on SEC.gov |
| Mar 30 | MAZE | Maze Therapeutics, Inc. | MEXER◷ | 7,500 | $10.42 | $78.2K | +71.4% | Open the original filing on SEC.gov |